2020
DOI: 10.5897/ajb2020.17251
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and molecular characteristics of extended spectrum beta-lactamase-producing uropathogenic Escherichia coli isolated from hospital attendees in Ebonyi State, Abakaliki

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
1
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 9 publications
2
1
1
Order By: Relevance
“…In this study, multiple ESBL-producing E. coli strains were identified to harbour blaCTX-M and blaTEM with a prevalence rate of 12 (40.0%). This is in line with the finding of other research in Nigeria, where ESBL-producing E. coli were discovered to harbour blaCTX-M and blaTEM in multiple instances, being prevalent at a rate of 15.3% (25).…”
Section: Discussionsupporting
confidence: 92%
“…In this study, multiple ESBL-producing E. coli strains were identified to harbour blaCTX-M and blaTEM with a prevalence rate of 12 (40.0%). This is in line with the finding of other research in Nigeria, where ESBL-producing E. coli were discovered to harbour blaCTX-M and blaTEM in multiple instances, being prevalent at a rate of 15.3% (25).…”
Section: Discussionsupporting
confidence: 92%
“…In addition, the resistance rate to cephalosporins were relatively high i.e., Cefotaxime, Cefoxtin Ceftazidime, Ceftriaxone was observed at 60-100% and is in support with the findings of Yan et al [56] were Carbapenem-resistant Klebsiella pneumoniae isolates demonstrated 78.2% and 75.6% resistant to ceftriaxone and ceftazidime with similar findings reporting cefoxitin 83.3%, ceftriaxone 100%, ceftazidime 95.8% [40]; ceftazidime 66.7% and ceftriaxone 92.3% [57] and more recent study documented carbapenem-resistant Klebsiella pneumoniae isolates 100% resistant to ceftriaxone and ceftazidime [58]. Also, this finding correlate with an earlier study in the same setting (Abakaliki) were resistant to cefotaxime (83.6%), ceftazidime (79.5%) and ceftriaxone (57.5%) were reported [59] while Adabara et al [60] in Minna reported resistant to cefotaxime (84.6%). This study conducted also established that most Carbapenem-resistant isolates are multidrug resistant (MDR), especially to 3rd and 4th generation cephalosporins.…”
Section: Key: N= Number Of Isolate Cpr-carbapenem Resistant Cps-carba...supporting
confidence: 85%
“…The MDR resistant trend of carbapenem-resistant isolates to trimethoprim/ sulfamethoxazole, amoxicillin/clavulanate, azetronam and tetracycline in this study has not changed from the reported pattern in earlier studies [40,59,61,62,63,64]. Additionally, the high percentages of Carbapenem-resistant isolates cross-resistance observed to various antimicrobials are of concern in clinical medicine, especially in intensive care units and other relevant unit.…”
Section: Key: N= Number Of Isolate Cpr-carbapenem Resistant Cps-carba...contrasting
confidence: 38%
“…Such variation in the proportion of ESBL-producers in different parts of the country may be attributable to various factors such as socio-economic conditions and common practice of drug misuse. Furthermore, eight (21.62%) isolates carried the bla CTX-M gene, which is lower than its prevalence reported in previous studies [47,50]. The distribution of ESBLs has evolved to a predominance of CTX-M enzymes, mainly with E. coli as one of the major carriers of ESBL encoding genes [51].…”
Section: Discussionmentioning
confidence: 70%